Jamp Pharma Group, a Canadian-owned pharmaceutical company based in Montréal, announced today the launch of Guanfacine XR, a generic version of the reference product INTUNIV XR® from Takeda ...

Takeda Pharmaceutical Co has agreed to pay $1.85 million to settle claims by consumers that its predecessor Shire PLC delayed the launch of a generic version of its ADHD drug Intuniv through an ...

Shire has not given detailed guidance, but says it expects 2010 revenue to be ahead of 2009, with sales of its core drugs, excluding Adderall XR, growing by 25 percent or more.